TTNP · Categories · Form 4

TTNP - SEC Form 4 insider transactions

Titan Pharmaceuticals Inc. (TTNP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TTNP

• 243d
  Director Ben-Tzvi Avraham returned 3,313 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 804d
  Choong Choon Hau converted options into 54,132 shares, increasing direct ownership by 1% to 3,802,100 units (SEC Form 4)

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1043d
  SEC Form 4: Greenberg Eric Howard was granted 50,000 shares

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1043d
  SEC Form 4: Natan David was granted 50,000 shares (Amendment)

  4/A - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1043d
  SEC Form 4: Chasey Peter Louis was granted 50,000 shares (Amendment)

  4/A - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1043d
  SEC Form 4: Mcmurdo Matthew Charles was granted 50,000 shares (Amendment)

  4/A - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1043d
  SEC Form 4: Lazar David E. was granted 100,000 shares

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1043d
  SEC Form 4: Ben-Tzvi Avraham was granted 50,000 shares

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1046d
  SEC Form 4 filed by Chasey Peter Louis

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1046d
  SEC Form 4 filed by Beebe Katherine

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1046d
  SEC Form 4 filed by Mcmurdo Matthew Charles

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1046d
  SEC Form 4 filed by Natan David

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1076d
  SEC Form 4 filed by Lazar David E. (Amendment)

  4/A - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1081d
  SEC Form 4 filed by Lazar David E.

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1229d
  SEC Form 4: Lazar David E. bought $56,287 worth of shares (57,500 units at $0.98)

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1431d
  SEC Form 4: Lazar David E. bought $1,922,882 worth of shares (2,226,190 units at $0.86)

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1592d
  SEC Form 4: Mcnab James R acquired 51,021 shares

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1615d
  SEC Form 4 filed by Akers Joseph A

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1615d
  SEC Form 4 filed by Macfarlane M David

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1615d
  SEC Form 4 filed by Mcnab James R

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1615d
  SEC Form 4 filed by Beebe Katherine

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1615d
  SEC Form 4 filed by Rubin Marc

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1944d
  SEC Form 4 filed by Katherine Beebe

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1944d
  SEC Form 4 filed by A Joseph Akers

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1944d
  SEC Form 4 filed by David M Macfarlane

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1944d
  SEC Form 4 filed by R James Mcnab

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
• 1944d
  SEC Form 4 filed by Marc Rubin

  4 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)

Other TTNP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends